|
Volumn 48, Issue 1, 1999, Pages 37-41
|
Heparin-induced thrombocytopenia thrombopenia;Thrombopenie induite par l'heparine
a
|
Author keywords
Danaparoid; Heparin induced thrombocytopenia; Hirudin; Platelet factor 4; Thrombosis
|
Indexed keywords
DANAPAROID;
HEPARIN;
LEPIRUDIN;
THROMBOCYTE FACTOR 4;
ANTIBODY;
ANTICOAGULANT AGENT;
BETA THROMBOGLOBULIN;
CHONDROITIN SULFATE;
DERMATAN SULFATE;
DRUG DERIVATIVE;
HEPARAN SULFATE;
HIRUDIN DERIVATIVE;
INTERLEUKIN 8;
PEPTIDE;
PPBP PROTEIN, HUMAN;
RECOMBINANT PROTEIN;
FIBRINOLYTIC THERAPY;
HUMAN;
REVIEW;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
THROMBOSIS;
TREATMENT INDICATION;
BLOOD;
CHEMICALLY INDUCED DISORDER;
DRUG MONITORING;
DRUG UTILIZATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
IMMUNOLOGY;
METABOLISM;
METHODOLOGY;
RISK FACTOR;
STANDARD;
TIME;
ANTIBODIES;
ANTICOAGULANTS;
BETA-THROMBOGLOBULIN;
CHONDROITIN SULFATES;
DERMATAN SULFATE;
DRUG MONITORING;
DRUG UTILIZATION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HEPARIN;
HEPARITIN SULFATE;
HIRUDINS;
HUMANS;
INTERLEUKIN-8;
PEPTIDES;
PLATELET COUNT;
PLATELET FACTOR 4;
RECOMBINANT PROTEINS;
RISK FACTORS;
THROMBOCYTOPENIA;
TIME FACTORS;
|
EID: 0032940879
PISSN: 00033928
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (13)
|